{"id":"https://openalex.org/W2134493465","doi":"https://doi.org/10.1007/978-1-4612-4596-4_1","title":"alpha-2 Adrenergic Receptors","display_name":"alpha-2 Adrenergic Receptors","publication_year":1988,"publication_date":"1988-01-01","ids":{"openalex":"https://openalex.org/W2134493465","doi":"https://doi.org/10.1007/978-1-4612-4596-4_1","mag":"2134493465"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4612-4596-4_1","doi":"https://doi.org/10.1007/978-1-4612-4596-4_1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4612-4596-4_1","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The alpha-2 Adrenergic Receptors","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W615039435","display_name":"The alpha-2 Adrenergic Receptors"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104046994","display_name":"David B. Bylund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David B. Bylund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5104046994"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7801,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.91749599,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":1.0},{"id":"https://openalex.org/keywords/clonidine","display_name":"clonidine","score":0.7289999723434448},{"id":"https://openalex.org/keywords/guanabenz","display_name":"guanabenz","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":0.7990000247955322},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.9589999914169312},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-antagonists","display_name":"alpha2-adrenoceptor antagonists","score":0.996999979019165},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.515999972820282},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.9179999828338623},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9020000100135803},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6240000128746033},{"id":"https://openalex.org/keywords/epinephrine","display_name":"epinephrine","score":0.8529999852180481},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":1.0}],"concepts":[{"id":"https://openalex.org/C2778680573","wikidata":"https://www.wikidata.org/wiki/Q5613542","display_name":"Guanabenz","level":4,"score":0.9068769216537476},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.8221805095672607},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.5933476686477661},{"id":"https://openalex.org/C13348194","wikidata":"https://www.wikidata.org/wiki/Q288084","display_name":"Alpha-2 adrenergic receptor","level":3,"score":0.5770882964134216},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5161677002906799},{"id":"https://openalex.org/C158453852","wikidata":"https://www.wikidata.org/wiki/Q4684738","display_name":"Adrenergic","level":3,"score":0.5130873918533325},{"id":"https://openalex.org/C2778196918","wikidata":"https://www.wikidata.org/wiki/Q4684744","display_name":"Adrenergic antagonist","level":4,"score":0.47450679540634155},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45679405331611633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45074301958084106},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44349661469459534},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.41849544644355774},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.41819101572036743},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4166533946990967},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3258066475391388},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.19671523571014404},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-4612-4596-4_1","doi":"https://doi.org/10.1007/978-1-4612-4596-4_1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4612-4596-4_1","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The alpha-2 Adrenergic Receptors","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8399999737739563,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W9807525","https://openalex.org/W21220908","https://openalex.org/W88434570","https://openalex.org/W627472209","https://openalex.org/W633594936","https://openalex.org/W1524721236","https://openalex.org/W1555121428","https://openalex.org/W1558267681","https://openalex.org/W1865252654","https://openalex.org/W1967325029","https://openalex.org/W1972081418","https://openalex.org/W1975070600","https://openalex.org/W1975180379","https://openalex.org/W1987426214","https://openalex.org/W1991218053","https://openalex.org/W1993238032","https://openalex.org/W1996972993","https://openalex.org/W1997761599","https://openalex.org/W2000247756","https://openalex.org/W2002074374","https://openalex.org/W2002294075","https://openalex.org/W2008632370","https://openalex.org/W2009156812","https://openalex.org/W2012335673","https://openalex.org/W2021852569","https://openalex.org/W2023140990","https://openalex.org/W2024604050","https://openalex.org/W2025593334","https://openalex.org/W2031154421","https://openalex.org/W2046895023","https://openalex.org/W2052325698","https://openalex.org/W2053147669","https://openalex.org/W2053499485","https://openalex.org/W2069459787","https://openalex.org/W2076071445","https://openalex.org/W2088116769","https://openalex.org/W2123629158","https://openalex.org/W2140654529","https://openalex.org/W2174016629","https://openalex.org/W2235192788","https://openalex.org/W2281938476","https://openalex.org/W2336350647","https://openalex.org/W2340748737","https://openalex.org/W2408148837","https://openalex.org/W2410745049","https://openalex.org/W2413254761","https://openalex.org/W2468488662","https://openalex.org/W2468643821","https://openalex.org/W2488867064","https://openalex.org/W3082796960","https://openalex.org/W3150656078","https://openalex.org/W4244072676"],"related_works":["https://openalex.org/W149127238","https://openalex.org/W2901639573","https://openalex.org/W1763219016","https://openalex.org/W2396158044","https://openalex.org/W2147123664","https://openalex.org/W2091735595","https://openalex.org/W1975064226","https://openalex.org/W7073577705","https://openalex.org/W1968462732","https://openalex.org/W1993897783"],"abstract_inverted_index":{"The":[0,91],"actions":[1],"of":[2,30,63,70,79,93,105],"epinephrine,":[3],"an":[4,82,87],"adrenal":[5],"hormone":[6],"and":[7,10,15,23,47,125,142,151,160],"central":[8,16],"neurotransmitter,":[9,17],"norepinephrine,":[11],"a":[12,28,103],"peripheral":[13],"sympathetic":[14],"are":[18,49],"mediated":[19],"through":[20],"alpha-1,":[21],"alpha-2,":[22],"beta-adrenergic":[24],"receptors.":[25,40],"In":[26],"addition,":[27],"variety":[29],"drugs":[31,132],"also":[32,57],"produce":[33],"their":[34],"effects":[35],"by":[36,121,149,153],"interacting":[37],"with":[38,138],"these":[39,131],"alpha-2":[41,88,95,109],"Adrenergic":[42],"agonists,":[43],"such":[44],"as":[45,98,166],"Clonidine":[46,55,71],"guanabenz,":[48],"widely":[50],"used":[51,58,74],"to":[52,59,115],"treat":[53],"hypertension.":[54],"is":[56,86,101,158],"ameliorate":[60,116],"the":[61,77,117,154,161,167],"symptoms":[62],"withdrawal":[64],"from":[65],"opiate":[66],"drugs.":[67],"Local":[68],"administration":[69],"has":[72,127],"been":[73,113,128],"successfully":[75],"in":[76],"treatment":[78],"glaucoma.":[80],"Mianserin,":[81],"effective":[83],"antidepressant":[84,99],"drug,":[85],"adrenergic":[89,96,110],"antagonist.":[90],"utility":[92],"other":[94],"antagonists":[97],"medications":[100],"currently":[102],"subject":[104],"intense":[106],"study.":[107],"Recently":[108],"agonists":[111],"have":[112],"demonstrated":[114],"cognitive":[118],"defects":[119],"exhibited":[120],"aged":[122],"nonhuman":[123],"primates,":[124],"it":[126],"suggested":[129],"that":[130],"may":[133,163],"be":[134,164],"helpful":[135],"for":[136],"patients":[137],"Alzheimer\u2019s":[139],"disease":[140],"(Arnsten":[141],"Goldman-Rakic,":[143],"1985).":[144],"These":[145],"keywords":[146,162],"were":[147],"added":[148],"machine":[150],"not":[152],"authors.":[155],"This":[156],"process":[157],"experimental":[159],"updated":[165],"learning":[168],"algorithm":[169],"improves.":[170]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}